Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Team Cohesion
NCT02302430Phase 1Completed
- Sponsor
- University of California, San Francisco
- Start
- Oct 2015
- Primary completion
- May 2018
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxytocin nasal spray in post-traumatic stress disorder (PTSD) (2 arms), sponsored by University of California, San Francisco. Primary endpoint: Change in score on computer game task at 2 hours. Started Oct 2015; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT02302430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02302430.